Therapy Areas: Oncology
Greenwich LifeSciences secures UK approval to expand Phase III breast cancer trial
22 July 2026 - US biopharmaceutical company Greenwich LifeSciences, Inc. (NASDAQ: GLSI) said on Wednesday it has received regulatory clearance to extend its Phase III FLAMINGO-01 trial into the United...
Elephas Biosciences partners with Invitrocue to promote elive platform in Singapore and Malaysia
22 July 2026 - Elephas Biosciences Corporation, developer of an innovative live tissue platform for immunotherapy response prediction, announced on Tuesday that it has entered into an international pa...
Lupin spins out two oncology programmes to Kaveri Therapeutics
21 July 2026 - India-based global pharmaceutical company Lupin Limited (BSE: 500257) (NSE: LUPIN) announced on Tuesday the strategic spin-out of two oncology programmes, LNP7457 (PRMT5) and LNP8701 (S...
Fuse Oncology launches new prescribing and treatment-intent solution FuseRx
21 July 2026 - Fuse Oncology, a structured AI platform for radiation oncology, announced on Monday the launch of FuseRx, a prescribing and treatment-intent solution for radiation oncology.According to...
Tempus agrees to acquire Personalis in USD1.5bn precision oncology deal
20 July 2026 - Personalis Inc (Nasdaq: PSNL), a provider of advanced genomics for precision oncology, announced on Monday that it has agreed to be acquired by technology firm Tempus AI Inc (NASDAQ: TE...
Evaxion to present three-year cancer vaccine data at ESMO Congress 2026
20 July 2026 - Evaxion A/S, a Denmark-based, clinical-stage TechBio company developing novel vaccines with its AI-Immunology platform, said on Friday that it will present three-year clinical efficacy ...